TYPTF (Entropy Neurodynamics) OCF Yield %: -18.45 (As of Jun. 27, 2026)


What is Entropy Neurodynamics OCF Yield %?

Entropy Neurodynamics TYPTF -45.63% OCF Yield % is -18.45 as of Jun. 27, 2026. The stock has 5 warning signs investors should review. Among 1,419 Biotechnology companies, Entropy Neurodynamics ranks worse than 55.25% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Entropy Neurodynamics's Trailing 12-Month Cash Flow from Operations is $-3.51 Mil, and Market Cap is $36.01 Mil. Therefore, Entropy Neurodynamics's OCF Yield % for today is -18.45%.

The historical rank and industry rank for Entropy Neurodynamics's OCF Yield % or its related term are showing as below:

TYPTF' s OCF Yield % Range Over the Past 10 Years
Min: -599.9   Med: -152.61   Max: -8.03
Current: -18.45


During the past 7 years, the highest OCF Yield % of Entropy Neurodynamics was -8.03%. The lowest was -599.90%. And the median was -152.61%.

TYPTF's OCF Yield % is ranked worse than
55.25% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs TYPTF: -18.45

Entropy Neurodynamics's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Entropy Neurodynamics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Entropy Neurodynamics OCF Yield % Related Terms


Entropy Neurodynamics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Entropy Neurodynamics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entropy Neurodynamics OCF Yield % Chart

Entropy Neurodynamics Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun25
OCF Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -31.96

Entropy Neurodynamics Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -28.53 -22.54 -10.61

TYPTF vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Entropy Neurodynamics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entropy Neurodynamics OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entropy Neurodynamics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Entropy Neurodynamics's OCF Yield % falls into.



Entropy Neurodynamics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Entropy Neurodynamics's OCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-5.059 / 15.828142
=-31.96%

Entropy Neurodynamics's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.725 * 2 / 32.512102
=-10.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -18.45 mean?
Entropy Neurodynamics (TYPTF) has a OCF Yield % of -18.45 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Entropy Neurodynamics and its competitors. According to the industry distribution chart, Entropy Neurodynamics ranks #784 out of 1419 companies in the Biotechnology industry, placing it in the top 55.3%.
Is Entropy Neurodynamics' OCF Yield % too high?
Entropy Neurodynamics' current OCF Yield % is -18.45. Based on the distribution chart, Entropy Neurodynamics ranks #784 out of 1419 companies in the Biotechnology industry, which is below the industry midpoint.
How does Entropy Neurodynamics' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Entropy Neurodynamics ranks #784 out of 1419 companies for OCF Yield %. This places Entropy Neurodynamics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Entropy Neurodynamics and its competitors. Entropy Neurodynamics's current OCF Yield % is -18.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entropy Neurodynamics stock overvalued right now?
Based on GuruFocus' analysis, Entropy Neurodynamics (TYPTF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 12% above its estimated fair value. The current OCF Yield % is -18.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Entropy Neurodynamics (TYPTF), the current OCF Yield % is -18.45 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entropy Neurodynamics Business Description

Other Exchanges ENP:Australia
Address 117 Camberwell Road,, Hawthorn East, Suite 1.01, Camberwell, Melbourne, VIC, AUS, 3123
Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's lead program is TRP-8803. TRP-8803 is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe.